Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Results from ongoing VAL-083 brain cancer trial

Dec. 13, 2013

Final results presented for glioblastoma multiforme trial of Cotara

Dec. 13, 2013

KNG-I-484C described as novel candidate for NSCLC

Dec. 12, 2013

Dual BCR-ABL and MNK kinase inhibitors developed for blast crisis chronic myeloid leukemia

Dec. 12, 2013

Incozen Therapeutics presents BIA-6 as a novel antitumor agent

Dec. 12, 2013

Novel endochin-like quinolones as cytochrome bc1 inhibitors for Plasmodium infection

Dec. 12, 2013

Buparlisib generally well tolerated in glioblastoma multiforme trial

Dec. 12, 2013

Minocycline may sensitize recurrent glioblastoma after bevacizumab failure

Dec. 12, 2013

Novartis presents novel anti-BAFF-R afucosylated human antibody

Dec. 11, 2013

Pharmacological data presented for a selective nAChR desensitizer

Dec. 11, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...